References: World Health Organization. Global tuberculosis report 2018. Geneva, Switzerland: World Health Organization, 2018.
Dodd P, Yuen C, Sismanidis C, Seddon J, Jenkins H. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health 2017; 5: e898-906.
Syridou G, Mavrikou M, Amanatidou V, Spyridis N, Prasad P, Papaventsis D, et al. Trends in the epidemiology of childhood tuberculosis in Greece. Int J Tuberc Lung Dis 2012; 16: 749-55.
European Centre for Disease Prevention and Control (ECDC)/World Health Organization Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2018 - 2016 data. Stockholm, Sweden: ECDC, 2018.
Seddon JA, Shingadia D. Epidemiology and disease burden of tuberculosis in children: a global perspective. Infect Drug Resist 2014; 7: 153-65.
Brewin P, Jones A, Kelly M, McDonald M, Beasley E, Sturdy P, et al. Is screening for tuberculosis acceptable to immigrants? A qualitative study J Public Health (Oxf) 2006; 28: 253-60.
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161: S22147.
Dandoulakis M, Roussos N, Karageorgopoulos DE, Yatromanolakis N, Falagas ME. Trends of tuberculin skin test positivity rate among schoolchildren in Attica, Greece. Scand J Infect Dis 2009; 41: 195-200.
Chang S, Wheeler LSM, Farrell KP. Public health impact of targeted tuberculosis screening in public schools. Am J Public Health 2002; 92: 1942-5.
Watkins RE, Brennan R, Plant AJ. Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis 2000; 4: 895-903.
Hellenic Centre for Disease Control and Prevention (KEELPNO). Epidemiological data for tuberculosis in Greece. Athens, Greece: KEELPNO, 2013.
A statement of the International Union against Tuberculosis and Lung Disease. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. Tuber Lung Dis 1994; 75: 179-81.
Available at: http://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhs/metadotika-kai-mh-metadotika-noshmata/c388-egkyklioi/5777-antifymatikos-emboliasmos. (accessed on May 12, 2019).
Available at: http://www.moh.gov.gr/articles/health/dieythynsh-dhmosias-ygieinhsmetadotika-kai-mh-metadotika-noshmata/c388-egkyklioi/5779-dienergeia-dermoantidrashs-mantoux. (accessed on May 12, 2019).
World Health Organization. BCG vaccine: WHO position paper, February 2018 - recommendations. Vaccine 2018; 36: 3408-10.
Demographic and social characteristics of the Resident Population of Greece according to the 2011 Population - Housing Census revision of 20/3/2014. Availbale at: http://www.statistics.gr/documents/20181/1215267/A1602_SAM01_DT_DC_00_2011_03_F_EN.pdf/cb10bb9f-6413-4129-b847-f1def334e05e.
Recommendations of the Greek Ministry of Health for the prevention of tuberculosis. 1991.
Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/1203-Annual-TB-Report.pdf. (accessed on May 12, 2019).
Mantadakis E, Arvanitidou V, Tsalkidis A, Ramatani A, Triantafillidou E, Trypsianis G, et al. Changes in tuberculin sensitivity among first-grade students of elementary schools in Evros, Greece due to immigration. Public Health 2009; 123: 618-22.
Papaventsis D, Nikolaou S, Karabela S, Ioannidis P, Konstantinidou E, Marinou I, et al. Tuberculosis in Greece: bacteriologically confirmed cases and anti-tuberculosis drug resistance, 1995-2009. Euro Surveill 2010; 15. pii: 19614.
Bothamley GH, Ditiu L, Migliori GB, Lange C. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur Respir J 2008; 32: 1023-30.
Perdikogianni C, Raissaki M, Christidou A, Galanakis E. Cavitary tuberculosis re-emerging in immigrant children. Respir Med Case Rep 2019; 26: 209-11.
Kanavaki S, Mantadakis E, Nikolaou S, Karambela S, Samonis G. Antimicrobial resistance of Mycobacterium tuberculosis isolates from children in Greece, 1994-2004. Int J Tuberc Lung Dis 2007; 11: 424-8.
Rallis D, Spoulou V, Theodoridou M, Critselis E, Michailidou E, Kavaliotis J, et al. Current epidemiology of childhood tuberculous meningitis in Greece: a 10-year population-based study. Int J Tuberc Lung Dis 2013; 17: 847-8.
Spyridis P, Tsolia M, Gelesme A, Moustaki M, Spyridis N, Sinaniotis C, et al. The impact of Greece's childhood tuberculosis screening programme on the epidemiological indexes in the greater Athens area. Int J Tuberc Lung Dis 2003; 7: 248-53.
Baldwin-Edwards M. Statistical data on immigrants in Greece: an analytic study of available data and recommendations for conformity with European Union standards. 2004. Available at: http://aei.pitt.edu/2870. (accessed on May 12, 2019).
Centers for Disease Control and Population. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000; 49: 1-51.
Faust L, McCarthy A, Schreiber Y. Recommendations for the screening of paediatric latent tuberculosis infection in indigenous communities: a systematic review of screening strategies among high-risk groups in low-incidence countries. BMC Public Health 2018; 18: 979.
Mohle-Boetani JC, Miller B, Halpern M, Trivedi A, Lessler J, Solomon SL, et al. School-based screening for tuberculous infection. A cost-benefit analysis. JAMA 1995; 274: 613-9.
No Comments.